Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Has results × bermekimab × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Colorectal Neoplasms 1

Interventions

Cyclophosphamide 785 Carboplatin 683 Paclitaxel 637 Bevacizumab 629 pembrolizumab 602 Cisplatin 597 Gemcitabine 535 Docetaxel 501 Rituximab 482 Radiotherapy 481 Dexamethasone 431 Nivolumab 409 Doxorubicin 384 Capecitabine 339 Fluorouracil 338 Etoposide 313 Oxaliplatin 291 Cytarabine 287 Pemetrexed 286 Lenalidomide 284 Prednisone 281 Erlotinib Hydrochloride 274 fludarabine phosphate 271 Leucovorin 263 fludarabine 261 Trastuzumab 254 Bortezomib 246 Filgrastim 246 Vincristine 244 Cetuximab 233

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01767857 2021-06-29

XCITE

Janssen Research & Development, LLC

Phase 3 Terminated

643 enrolled 16 charts

Gastrointestinal

Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡